| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/17/2004 | US20040116675 Silenced anti-cd28 antibodies and use thereof |
| 06/17/2004 | US20040116674 Separation of polypeptide monomers |
| 06/17/2004 | US20040116672 Human sel-10 polypeptides and polynucleotides that encode them |
| 06/17/2004 | US20040116671 Novel polypeptides and nucleic acids encoding same |
| 06/17/2004 | US20040116670 Comprises polypeptides associated with cytoplasmic network of protein fibers that mediate cell shape, structure, and movement for diagnosis, treatment and prevention of cell proliferative, viral, neurological disorders |
| 06/17/2004 | US20040116669 Prostaglandin ep1 receptor |
| 06/17/2004 | US20040116661 Virulence peptides from attenuated microorganism for identifying microbiocides and developing vaccines which prevent infection; veterinary medicine |
| 06/17/2004 | US20040116367 Production of "biological carriers" for induction of immune responses and inhibition of viral replication |
| 06/17/2004 | US20040116338 Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases |
| 06/17/2004 | US20040116337 Soluble cyclic analogues of beta amyloid peptide |
| 06/17/2004 | US20040116333 Administering to the individual a multimeric compound that binds to at least two P-Selectin Glycoprotein Ligand 1 (PSGL-1) proteins on the surface of a T cell to induces a signal transduction pathway that results in the death of the T cell |
| 06/17/2004 | US20040115814 Using site specific recombination to insert heterologous nucleotide sequences into genomes and monitor transcritional expression in cells; stable, high level expression systems |
| 06/17/2004 | US20040115785 Protein purification |
| 06/17/2004 | US20040115772 Methods of inhibiting Helicobacter pylori |
| 06/17/2004 | US20040115764 Comprises nucleotide sequences coding horse immunoglobulin for use in diagnosis of allergies in animals; veterinary medicine |
| 06/17/2004 | US20040115761 Polypeptides and nucleic acids encoding same |
| 06/17/2004 | US20040115738 Polypeptides having a triggering nk activity and biological applications |
| 06/17/2004 | US20040115728 Detecting lipocalin |
| 06/17/2004 | US20040115700 Comprises nucleotide sequences coding transcriptional splice variants of hippocampal and mammary gland negative regulatory protein for use in diagnosis and treatment of alzheimer's disease |
| 06/17/2004 | US20040115698 Interleukin 17 receptor-like protein |
| 06/17/2004 | US20040115695 Methods for generating enhanced antibody producing cell lines with improved growth characteristics |
| 06/17/2004 | US20040115656 Androgen receptor down-regulatory-associated proteins(ARDAPs) for use in reduction of transactivation activity of androgen receptors and treatment of tumors; gene expression inhibition and anticarcinogenic agents |
| 06/17/2004 | US20040115619 Immunoglobulin which binds hepatitis c viral envelope proteins and prevents and treats viral diseases; immunotherapy; viricides |
| 06/17/2004 | US20040115615 Comprises amino acid sequences capable of inducing lymphadenopathy immune response without antagonizing cytotoxic lymphocytes; viricides and prevention of viral diseases |
| 06/17/2004 | US20040115220 Vaccine |
| 06/17/2004 | US20040115215 Recombinant botulinum toxins with a soluble C-terminal portion, an N-terminal portion and a light chain |
| 06/17/2004 | US20040115206 by contacting with an anti-L1CAM antibody or L1CAM-binding fragment thereof to inhibit cell growth or induce cell death |
| 06/17/2004 | US20040115205 Use of antibodies against the MUC18 antigen |
| 06/17/2004 | US20040115204 iinhibiting proliferation of a antigenmyeloma tumor cell expressing a ganglioside by contacting the cell with an antibody that specifically binds to the ganglioside |
| 06/17/2004 | US20040115203 administering a radiolabeled antibody that specifically binds to an agent causing the infection. |
| 06/17/2004 | US20040115202 monospecific antibody which specifically binds an epitope of a mammalian DPPIV (dipeptidyl peptidase IV, also known as CD26). |
| 06/17/2004 | US20040115201 treatment of an apoptosis-related disease by administering an inhibitor of the MKLP1 polypeptide; diagnostic and prognostic processes in connection with apoptosis relates diseases, and screening processes aimed at obtaining MKLP1 modulators. |
| 06/17/2004 | US20040115200 administering to cerebrospinal fluid anti-TNF antibodies, fragments and regions thereof that are specific for human tumor necrosis factor- alpha |
| 06/17/2004 | US20040115198 Activation of lymphocyte populations expressing NKG2D using anti-NKG2D antibodies and ligand derivatives |
| 06/17/2004 | US20040115197 Remedies for infant chronic arthritis-relating diseases |
| 06/17/2004 | US20040115196 H chain polypeptide of a recombinant antibody against human TNF alpha |
| 06/17/2004 | US20040115195 treating bone disorders resulting in increased trabecular bone formation, decreased osteoblast and osteocyte apoptosis and increased osteoprogenitor differentiation |
| 06/17/2004 | US20040115194 can be administered prophylactically |
| 06/17/2004 | US20040115193 Internalizing anti-CD-74 antibodies and methods of use |
| 06/17/2004 | US20040115191 Method for treating psoriasis |
| 06/17/2004 | US20040115190 Methods and agents modulating upa/upar activity |
| 06/17/2004 | US20040115128 Targeting endothelium for tissue-specific delivery of agents |
| 06/17/2004 | DE10256042A1 Verfahren zur Selektion von Zellen, die spezifisch bindende Moleküle produzieren A method of selecting cells that produce specific binding molecules |
| 06/17/2004 | CA2836951A1 Prion protein ligands and methods of use |
| 06/17/2004 | CA2508580A1 Methods of therapy and diagnosis using targeting of cells that express ly-9 |
| 06/17/2004 | CA2508519A1 Recombinant immunotoxin and use in treating tumors |
| 06/17/2004 | CA2508375A1 Antibodies directed to tumor necrosis factor and uses thereof |
| 06/17/2004 | CA2508214A1 Antibodies directed to phospholipase a2 and uses thereof |
| 06/17/2004 | CA2507936A1 Prion protein ligands and methods of use |
| 06/17/2004 | CA2507711A1 Wall teichoic acid as a target for anti-staphylococcal therapies and vaccines |
| 06/17/2004 | CA2507709A1 Therapeutic and diagnostic agents |
| 06/17/2004 | CA2507494A1 Rationally designed antibodies |
| 06/17/2004 | CA2507080A1 Humanized antibodies against monocyte chemotactic proteins |
| 06/17/2004 | CA2507077A1 Methods and compositions for inducing apoptosis in cancer cells |
| 06/17/2004 | CA2507055A1 Treatment of prion-induced diseases by administration of anti-prion antibodies |
| 06/17/2004 | CA2507004A1 Assay for identifying antibody producing cells |
| 06/17/2004 | CA2506744A1 Plant production of immunoglobulins with reduced fucosylation |
| 06/17/2004 | CA2506629A1 Modified antibodies stably produced in milk and methods of producing same |
| 06/17/2004 | CA2506202A1 Methods and kit for measuring elastin degradation product and method and kit for detecting aortic dissection |
| 06/17/2004 | CA2453387A1 Compositions and methods related to nitrotyrosine-containing compounds as antigenic agents |
| 06/16/2004 | EP1429143A1 Method of selecting binding molecule |
| 06/16/2004 | EP1428881A1 Hematopoietic stem cell proliferation regulators and polynucleotides encoding the same |
| 06/16/2004 | EP1428880A1 Kidney-specific urate transporter and gene thereof |
| 06/16/2004 | EP1428835A1 Antibody and use of the same |
| 06/16/2004 | EP1428537A1 Stabilized preparations containing antibody |
| 06/16/2004 | EP1428024A2 Preparation of highly-purified plasma membranes |
| 06/16/2004 | EP1427841A2 Nucleic acid-associated proteins |
| 06/16/2004 | EP1427827A2 Synthetic hcv envelope proteins and their use for vaccination |
| 06/16/2004 | EP1427825A2 Cdna encoding the human alpha2 delta4 calcium channel subunit |
| 06/16/2004 | EP1427819A2 Lactobacillus n-deoxyribosyl transferases, corresponding nucleotide sequences and their uses |
| 06/16/2004 | EP1427758A2 Compositions and methods of treating diabetes |
| 06/16/2004 | EP1427753A2 Peptides and proteins binding to glu-pro motifs, therapeutical compositions containing them and their applications |
| 06/16/2004 | EP1427752A2 New hepatitis c virus genotype, and its use as prophylactic, therapeutic and diagnostic agent |
| 06/16/2004 | EP1427744A2 A system for antibody expression and assembly |
| 06/16/2004 | EP1427432A2 Methods of healing or preventing inflammation, damage and other changes that occur prior to, during or immediately after a myocardial event with thymosin beta 4, analogues, isoforms and other derivatives |
| 06/16/2004 | EP1427377A2 Methods and compositions for treating or preventing skin disorders using binding agents specific for prostate specific membrane antigen |
| 06/16/2004 | EP1258018A4 REAGENTS, METHODS AND KITS FOR DETECTING i BACILLUS THURINGIENSIS /i PROTEINS |
| 06/16/2004 | EP1232176A4 Tumour suppressor factor |
| 06/16/2004 | EP0787299B1 Receptor for a bacillus thuringiensis toxin |
| 06/16/2004 | EP0580737B1 Heterodimeric receptor libraries using phagemids |
| 06/16/2004 | CN1505678A Lactic acid bacteria as agents for treating and preventing allergy |
| 06/16/2004 | CN1505528A Immunogen comprising ligand bound hiv envelpe protein |
| 06/16/2004 | CN1505526A Compositions and methods for wt1 specific immunotherapy |
| 06/16/2004 | CN1504752A Vaughan Tristan J. |
| 06/16/2004 | CN1504476A Polynucleotide for identifying polypeptide OT3 and coding OT3 of tumor cell and uses thereof |
| 06/16/2004 | CN1153854C Ferro-nickel alloy electroplating process for copper plate working surface of continuously casting crystallizer |
| 06/16/2004 | CN1153780C Protein with thrombopoiesis substance activity |
| 06/16/2004 | CN1153589C Treatment of infertility and enhancement of fertilization capacity in mammalian males |
| 06/15/2004 | US6750328 Antibodies for detection of water treatment polymers |
| 06/15/2004 | US6750327 Compositions and method for determining the presence of human PTTG peptide in a sample |
| 06/15/2004 | US6750326 Method for separating cells using immunorosettes |
| 06/15/2004 | US6750325 CD3 specific recombinant antibody |
| 06/15/2004 | US6750324 Agents and methods for treatment of diseases associated with amyloid deposits of a beta in the brain such as alzheimer's disease; entail administering agents that induce a beneficial immunogenic response against the amyloid deposit |
| 06/15/2004 | US6750323 Platelet activation protein |
| 06/15/2004 | US6750198 Treating disorders characterized by a reduction in pigmentation comprising administering an effective amount of the protein dcoh |
| 06/15/2004 | US6750194 Administering to the subject a safe and effective amount of a vpac receptor agonist selected from the group consisting of ro 25-1553, and pacap-38 |
| 06/15/2004 | US6750041 Homologous recombination antibody expression system for murine cells |
| 06/15/2004 | US6750034 Useful as therapeutic agents for cancer, skin disorders, neuropathic pain, inflammatory, or coagulation diathesis/thrombosis; may also be useful for laundry detergents and skin care products; derived from humans |
| 06/15/2004 | US6750026 To diagnose diseases relating to under- or over-expression of hfgan72 receptor ligands; for treatment of obesity, diabetes, anorexia nervosa, bulimia, cachexia, chronic renal failure, congestive heart failure |
| 06/15/2004 | US6749858 Nucleotide sequences coding polypeptide for use in the prevention of streptoccocus infection |